THE EFFECT OF SEROTONERGIC AGENTS ON HALOPERIDOL-INDUCED CATALEPSY

被引:136
作者
HICKS, PB
机构
关键词
D O I
10.1016/0024-3205(90)90365-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The effect of various classes of serotonergic agents on haloperidol-induced catalepsy was evaluated in male Sprague-Dawley rats. The 5-HT-1A agonists buspirone, ipsapirone and 8-OH-DPAT all potently reversed catalepsy. The mixed 5-HT-1A and 5-HT-1B agonist RU 24969 reversed catalepsy only at the highest dose tested. The non-selective 5-HT-1 antagonist (1)-propranolol did not affect catalepsy. The 5-HT-2 agonist DOI and 5-HT-2 antagonist mesulergine both reversed catalepsy. ICS 205-930 (5-HT-3 antagonist) reversed catalepsy at low doses only. Another 5-HT-3 antagonist, GR 38032F, had no effect on catalepsy. These studies suggest that 5-HT-1A and 5-HT-2 receptor sites are important in the serotonergic modulation of haloperidol-induced catalepsy. © 1990.
引用
收藏
页码:1609 / 1615
页数:7
相关论文
共 32 条
  • [1] EFFECT OF DRUGS INFLUENCING CENTRAL SEROTONERGIC MECHANISMS ON HALOPERIDOL-INDUCED CATALEPSY
    BALSARA, JJ
    JADHAV, JH
    CHANDORKAR, AG
    [J]. PSYCHOPHARMACOLOGY, 1979, 62 (01) : 67 - 69
  • [2] PROPOSALS FOR THE CLASSIFICATION AND NOMENCLATURE OF FUNCTIONAL RECEPTORS FOR 5-HYDROXYTRYPTAMINE
    BRADLEY, PB
    ENGEL, G
    FENIUK, W
    FOZARD, JR
    HUMPHREY, PPA
    MIDDLEMISS, DN
    MYLECHARANE, EJ
    RICHARDSON, BP
    SAXENA, PR
    [J]. NEUROPHARMACOLOGY, 1986, 25 (06) : 563 - 576
  • [3] THE ROLE OF 5-HYDROXYTRYPTAMINE IN DOPAMINE-DEPENDENT STEREOTYPED BEHAVIOR
    CARTER, CJ
    PYCOCK, CJ
    [J]. NEUROPHARMACOLOGY, 1981, 20 (03) : 261 - 265
  • [4] [H-3] MESULERGINE, A SELECTIVE LIGAND FOR SEROTONIN-2 RECEPTORS
    CLOSSE, A
    [J]. LIFE SCIENCES, 1983, 32 (21) : 2485 - 2495
  • [5] EFFECTS OF THE 5-HT3 RECEPTOR ANTAGONIST, GR38032F, ON RAISED DOPAMINERGIC ACTIVITY IN THE MESOLIMBIC SYSTEM OF THE RAT AND MARMOSET BRAIN
    COSTALL, B
    DOMENEY, AM
    NAYLOR, RJ
    TYERS, MB
    [J]. BRITISH JOURNAL OF PHARMACOLOGY, 1987, 92 (04) : 881 - 894
  • [6] SEROTONINERGIC MODULATION OF DOPAMINE RESPONSE FROM NUCLEUS ACCUMBENS
    COSTALL, B
    NAYLOR, RJ
    MARSDEN, CD
    PYCOCK, CJ
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1976, 28 (06) : 523 - 526
  • [7] COSTALL B, 1975, NEUROPHARMACOLOGY, V14, P859, DOI 10.1016/0028-3908(75)90114-8
  • [8] STEREOTYPED AND CIRCLING BEHAVIOR INDUCED BY DOPAMINERGIC AGONISTS AFTER LESIONS OF MIDBRAIN RAPHE NUCLEI
    COSTALL, B
    NAYLOR, RJ
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1974, 29 (02) : 206 - 222
  • [9] COSTALL B, 1987, BR J PHARM P S, V90, P89
  • [10] OPEN PILOT TRIAL OF RITANSERIN IN PARKINSONISM
    DENOORDHOUT, AM
    DELWAIDE, PJ
    [J]. CLINICAL NEUROPHARMACOLOGY, 1986, 9 (05) : 480 - 484